IFPMA Outlines Plan For Fighting Counterfeit Drugs
This article was originally published in PharmAsia News
HONG KONG - The threat of counterfeit anti-infective drugs is rising rapidly, even as pharmaceutical companies, regulators and industry associations develop new strategies to deal with the problem
You may also be interested in...
MUMBAI - Years of strong opposition from the Indian government, bolstered by recent support in that effort by some Latin American, African and South-East Asian countries, has exerted pressure on the World Health Assembly to establish a working group to handle the controversy surrounding the definition of "substandard" and "counterfeit" drugs
Chinese Distributor Of Counterfeit Pharmaceuticals Sentenced To Prison For 78 Months, $1.286 Million In Restitution To Pfizer And Lilly
SHANGHAI - The 5th Circuit U.S. Court of Appeals re-sentenced Kevin Xu, owner of Pacific Orient International, a pharmaceutical distributor in China, to prison for conspiring to distribute counterfeit and misbranded drugs, United States Attorney José Angel Moreno announced April 23
HONG KONG - Drug companies are stepping up efforts to fight counterfeit products that are emerging around the world as potential profits grow and penalties, compared to those associated with dealing in illegal narcotics, are relatively low